跳至主要内容
临床试验/NCT00639444
NCT00639444已完成不适用

Infant Nutrition and Development of Celiac Disease in Genetically At-risk Babies: a Dietary Intervention Study at Weaning

Università Politecnica delle Marche2 个研究点 分布在 1 个国家目标入组 703 人开始时间: 2004年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
703
试验地点
2
主要终点
prevalence of active CD

研究概览

简要总结

The purpose of this study is to determine whether age at introduction of gluten-containing cereals (e.g. wheat) plays a role in influencing the risk of celiac disease (CD) development in infants with a first-degree relative affected by CD.

详细描述

We undertook a prospective study to establish the incidence of CD autoimmunity related to the timing of gluten exposure in at-risk infants. Infants at family risk for CD (at least one first-degree relative affected) are enrolled in this prospective, multicentre, intervention study conducted in Italy. Infants are randomly assigned to introduce gluten at either 4-6 or 12 months (groups A and B, respectively) and then enter a follow-up period of 5 years. Duration of breastfeeding and types of formulas, adherence to the dietary plan, amount of gluten administered, and clinical data are collected by phone or direct interview at 4, 7, 9, and 12 months of age. HLA (Human Leucocyte Antigene) status and CD serology (anti-transglutaminase and other autoantibodies) are tested at 15, 24, 36 and 60 months of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Day 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Newborn in a family where a first-degree relative is already affected with biopsy-proven CD

排除标准

  • 未提供

结局指标

主要结局

prevalence of active CD

时间窗: 5 years of age

次要结局

  • prevalence of CD-related autoantibodies (IgA anti-transglutaminase)(age 2, 3 and 5 years)

研究者

发起方
Università Politecnica delle Marche
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlo Catassi, M.D.

Associate Professor

Università Politecnica delle Marche

研究点 (2)

Loading locations...

相似试验